Human resources in health have deficiencies in numbers, distribution and quality of the health workforce, and reportedly low productivity(WHO, 2010). In 2012, with total population 239.871.000, Indonesia have adult mortality rate(probability of dying between 15 and 60 years per 1000 population) for both sexes is 190 higher than global average that is 176. With maternal mortality ratio per 100.000 live births is 220 higher than global average that is 210. Communicable diseases are a major cause of morbidity and mortality in Indonesia. Nearly 250 people die of tuberculosis (TB) every day, with over half a million new cases estimated to occur every year (WHO GTB 2009). Malaria remains a major vector-borne disease in large parts of Indonesia. Large scale outbreaks of dengue haemorrhagic fever are reported every year. Although leprosy has been eliminated at national level, Indonesia ranks third in terms of the global burden. At the end of 2006, an estimated 293.200 Indonesians were living with HIV-AIDS (National AIDS Commission Publication, 2009). Besides, an epidemiological transition towards noncommunicable diseases (NCDs) is a challenge for Indonesia. Chronic conditions such as cancer, cardiovascular diseases, metabolic disorders and tobacco dependence represent a real burden to the country in terms of cost, suffering and human lives.
Total expenditure on health per capita in Indonesia (Int $, 2010) is 112, and total expenditure on health as % of GDP (2010) is 2,6 relatively little compared with neighboring Malaysia and Thailand, The estimated total expenditure on health per capita in 2003 was US$ 33 in Indonesia compared with US$ 149 in Malaysia and US$ 90 in Thailand.
Indicators show that the health situation of mothers, children and adolescents in Indonesia still has much room for improvement. Mortality rates for children (less than five years) and infants (under one year) remain at 46 and 32 deaths per 1000 live births, respectively, All estimates confirm that the maternal mortality ratio (307/100 000 live births) in Indonesia is among the highest in the South-East Asia Region (Indonesia Demographic and Health Survey 2002-2003). The lifetime risk of a mother dying of causes relatedto childbirth is estimated to be 1 in 65 — compared with 1 in 1100 in Thailand (WHO 2002). Responding effectively to these complex disease patterns and potential threats to health is likely to remain a major set of challenges for the country during the coming years. Health are heading towards becoming a major public problem, requiring sustained prevention and control of the risk factors involved. However, the major challenge ahead will be to implement the strategy and to develop multisectoral public policies in support of the strategy. While further support is required to achieve an effective public health policy in Indonesia. This motivate us develop this company focus on developing innovative health products to solve health problems in Indonesia.
Build innovative health products based on solution, practical, and strategic to achieve justice and welfare of health in Indonesia.
1. Developing health social enterpreneurship to independencing innovative health products development
2. Collaborate scientific field and applicable field to develop innovative health products
3. Connect interdisciplinary science and health science to develop innovatove health products